Acute Defibrillation Performance of a Novel Can-less Shock Pathway

Inclusion Criteria: * Subjects meeting class 1, 2a or 2b indication for ICD implantation * Age \>18 * 32 \> Body Mass Index (BMI) \> 25 * 190 \> Height \> 165 cm * 120 \> Waist size \> 90 cm Exclusion Criteria: * Any condition that precludes the subject's ability to comply with the study requirements, including completion of the study * Female who is pregnant or breastfeeding; * Female who is of childbearing age who does not use reliable contraception methods (e.g. contraceptive pills, Intra-Uterine Device, estrogen-containing plasters) or had a positive pregnancy test * An acute infection requiring antibiotics two weeks prior to surgery * Participation in any other investigational study in the time ICD implantation is planned, unless there is written consent from the study sponsor; * Use of the antiarrhythmic drug Amiodarone (Cordarone, Sedacoron, Adenosine or other drugs) in the last 6 months before participation in the clinical trial; * Existence of large permanent electrodes (e.g. epicardial electrodes), more than 3 permanent endocardial electrodes or any other metal object implanted in the upper part of your body; * Any of the following cardiac diseases: protracted New York Heart Association (NYHA) class III or IV heart failure , Left Ventricular Ejection Fraction (LVEF) \< 20% or an enlarged or hypertrophied heart * Pulmonary hypertension patient, either with a history of moderate or severe pulmonary hypertension or by estimated pulmonary pressure above 45 (by cardiac echo test). * Chronic Obstructive Pulmonary Disease (COPD) patient that have been hospitalized in the last 12 months for COPD related reasons, require oxygen support or steroid based therapeutic support. * Subjects with severely impaired kidney function as measured by a Cockcroft-Gault Glomerular Filtration Rate (GFR) with an estimated GFR ≤ 29. * Subjects with prior abdominal surgery in the upper abdomen, previous upper abdominal trauma or anatomical deformities of the chest or upper abdomen * Subjects with known bleeding diathesis.